Related Experiment Video

Updated: Aug 17, 2026

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
07:20

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 14, 2011

B7-independent inhibition of T cells by CTLA-4

Shunsuke Chikuma1, Abul K Abbas, Jeffrey A Bluestone

  • 1University of California at San Francisco Diabetes Center and Department of Medicine, University of California, San Francisco, CA 94143, USA.

Journal of Immunology (Baltimore, Md. : 1950)
|June 24, 2005
PubMed

Insights

Cytotoxic T-Lymphocyte-Associated protein 4 (CTLA-4) inhibits T cell responses. This study shows CTLA-4’s inhibitory function does not require binding to its ligands, B7-1/B7-2, highlighting the importance of CTLA-4 signaling.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cellular Biology

Background:

  • Cytotoxic T-Lymphocyte-Associated protein 4 (CTLA-4) is a key regulator of T cell activation and immune tolerance.
  • CTLA-4's inhibitory function is traditionally attributed to its binding to B7-1/B7-2 ligands, competing with CD28 and delivering negative signals.

Purpose of the Study:

  • To investigate whether B7 ligand binding is essential for CTLA-4's inhibitory activity.
  • To elucidate the role of CTLA-4 signaling independent of ligand interaction in T cell regulation.

Main Methods:

  • Utilized CTLA-4 knockout T cells and a B7-nonbinding CTLA-4 mutant.
  • Assessed T cell proliferation, cytokine production, and T cell receptor (TCR)-mediated ERK activation.
  • Examined the in vivo effects of a ligand-nonbinding CTLA-4 mutant in CTLA-4-deficient mice.

Main Results:

  • CTLA-4 knockout T cells exhibited hyperresponsiveness in the absence of B7 ligands.
  • Expression of a B7-nonbinding CTLA-4 mutant suppressed T cell proliferation, cytokine release, and ERK activation.
  • Transgenic expression of the ligand-nonbinding CTLA-4 mutant ameliorated lethal lymphoproliferation in CTLA-4-deficient mice.

Conclusions:

  • B7 ligand binding is not essential for CTLA-4's inhibitory function.
  • CTLA-4 signaling plays a critical role in regulating T cell activation, independent of its interaction with B7 ligands.

More Related Videos

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.